Pfizer Must Pay $141M For Neurontin Marketing
13 CommentsBy Ed Silverman // March 25th, 2010 // 7:56 pm
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
• Pharma Blog » 2010
Pharmalot March, 2010 Archive
Psychiatrists And Pharma: Undue Influence?
17 CommentsBy Ed Silverman // March 25th, 2010 // 8:54 am
Merck, Groundwater Pollution & Sick Neighbors
4 CommentsBy Ed Silverman // March 25th, 2010 // 7:39 am
FDA Needs A Decade To Rebuild: Chief Scientist
14 CommentsBy Ed Silverman // March 25th, 2010 // 6:50 am
Genzyme To Receive Consent Decree From The FDA
3 CommentsBy Ed Silverman // March 24th, 2010 // 8:40 am
Avandia, Clinical Trials And Independent Analysis
14 CommentsBy Ed Silverman // March 24th, 2010 // 8:03 am
Neurontin: ‘A Good Drug… Marketed By Bad People’
15 CommentsBy Ed Silverman // March 24th, 2010 // 7:32 am
Should The FDA Be Able To Reevalute Products?
17 CommentsBy Ed Silverman // March 23rd, 2010 // 6:16 am